Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study von Yıldırım, Hasan Çağrı, Mutlu, Emel, Chalabiyev, Elvin, Özen, Miraç, Keskinkılıç, Merve, Ön, Sercan, Çelebi, Abdussamet, Dursun, Bengü, Acar, Ömer, Kahraman, Seda, Aykan, Musa Barış, Kaman, Ömür, Doğan, Akif, Erdoğan, Atike Pınar, Melisa Celayir, Özde, Günenç, Damla, Güven, Deniz Can, Vedat Bayoğlu, İbrahim, Yavuzşen, Tuğba, Hacıbekiroğlu, İlhan, İnanç, Mevlüde, Kılıçkap, Saadettin, Yalçın, Şuayib, Aksoy, Sercan

Volltext

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in m... von Yıldırım, Hasan Çağrı, Kutlu, Yasin, Mutlu, Emel, Aykan, Musa Barış, Korkmaz, Mustafa, Yalçın, Selim, Şakalar, Teoman, Celayir, Özde Melisa, Kayıkçıoğlu, Erkan, Aslan, Ferit, Hafızoğlu, Emre, Altıntaş, Yunus Emre, Keskinkılıç, Merve, Chalabiyev, Elvin, Çelebi, Abdussamet, Dursun, Bengü, Kapar, Caner, Özen, Miraç, Acar, Ömer, Dülgar, Özgecan, Kut, Engin, Biter, Sedat, Kus, Fatih, Almuradova, Elvina, Erdoğan, Atike Pınar, Saray, Seray, Güven, Deniz Can, Şimşek, Eda Tanrıkulu, Üskent, Necdet, Kemal, Yasemin, Çakar, Burcu, Açıkgöz, Özgür, Kılıçkap, Saadettin, Aksoy, Sercan

Volltext

Evaluation of HER2 overexpression, clinicopathological characteristics, and factors affecting survival in gastric cancer von Celayir, Ozde Melisa

Volltext

Turkish Adaptation of QLQ-SH22 Quality of Sexual Life Assessment Scale in Cancer Patients - Validity and Reliability Study von Eris, Suveyda Burcak, Celayir, Ozde Melisa, Tasci, Elif Senocak, Sertdemir, Ibrahim, Er, Ozlem

Volltext

Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer von Celayir, Ozde Melisa, Selcukbiricik, Fatih, Tanik, Canan, Altuntas, Yuksel

Volltext

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy von Karacin, Cengiz, Oksuzoglu, Berna, Demirci, Ayşe, Keskinkılıç, Merve, Baytemür, Naziyet Köse, Yılmaz, Funda, Selvi, Oğuzhan, Erdem, Dilek, Avşar, Esin, Paksoy, Nail, Demir, Necla, Göksu, Sema Sezgin, Türker, Sema, Bayram, Ertuğrul, Çelebi, Abdüssamet, Yılmaz, Hatice, Kuzu, Ömer Faruk, Kahraman, Seda, Gökmen, İvo, Sakin, Abdullah, Alkan, Ali, Nayır, Erdinç, Uğraklı, Muzafer, Acar, Ömer, Ertürk, İsmail, Demir, Hacer, Aslan, Ferit, Sönmez, Özlem, Korkmaz, Taner, Celayir, Özde Melisa, Karadağ, İbrahim, Kayıkçıoğlu, Erkan, Şakalar, Teoman, Öktem, İlker Nihat, Eren, Tülay, Erul, Enes, Mocan, Eda Eylemer, Kalkan, Ziya, Yıldırım, Nilgün, Ergün, Yakup, Akagündüz, Baran, Karakaya, Serdar, Kut, Engin, Teker, Fatih, Demirel, Burçin Çakan, Karaboyun, Kubilay, Almuradova, Elvina, Ünal, Olçun Ümit, Oyman, Abdilkerim, Işık, Deniz, Okutur, Kerem, Öztosun, Buğra, Gülbağcı, Burcu Belen, Kalender, Mehmet Emin, Şahin, Elif, Seyyar, Mustafa, Özdemir, Özlem, Selçukbiricik, Fatih, Kanıtez, Metin, Dede, İsa, Gümüş, Mahmut, Gökmen, Erhan, Yaren, Arzu, Menekşe, Serkan, Ebinç, Senar, Aksoy, Sercan, İmamoğlu, Gökşen İnanç, Altınbaş, Mustafa, Çetin, Bülent, Uluç, Başak Oyan, Er, Özlem, Karadurmuş, Nuri, Erdoğan, Atike Pınar, Artaç, Mehmet, Tanrıverdi, Özgür, Çiçin, İrfan, Şendur, Mehmet Ali Nahit, Oktay, Esin, Bayoğlu, İbrahim Vedat, Paydaş, Semra, Aydıner, Adnan, Salim, Derya Kıvrak, Geredeli, Çağlayan, Yavuzşen, Tuğba, Doğan, Mutlu, Hacıbekiroğlu, İlhan

Volltext